Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B. Clinics [Internet]. 2013 Oct. 1 [cited 2024 May 20];68(10):1325-32. Available from: https://www.revistas.usp.br/clinics/article/view/77009